The effects of deucravacitinib on three cases of systemic sclerosis associated with psoriasis

Journal Article Accepted manuscript The effects of deucravacitinib on three cases of systemic sclerosis associated with psoriasis Get access Takemichi Fukasawa, M.D., Ph.D, Takemichi Fukasawa, M.D., Ph.D Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, JapanDepartment of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Asako Yoshizaki-Ogawa, M.D., Ph.D, Asako Yoshizaki-Ogawa, M.D., Ph.D Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Ayumi Yoshizaki, M.D., Ph.D, Ayumi Yoshizaki, M.D., Ph.D Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, JapanDepartment of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, JapanSystemic sclerosis center, The University of Tokyo Hospital, Tokyo, Japan Address for correspondence and reprints requests: Dr Ayumi Yoshizaki, Department of Dermatology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo. Phone: 81-3-5800-8661, Fax: 81-3-3814-1503, E-mail: [email protected] Search for other works by this author on: Oxford Academic PubMed Google Scholar Shinichi Sato, M.D., Ph.D Shinichi Sato, M.D., Ph.D Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, JapanSystemic sclerosis center, The University of Tokyo Hospital, Tokyo, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, keaf019, https://doi.org/10.1093/rheumatology/keaf019 Published: 09 January 2025 Article history Received: 25 October 2024 Revision received: 20 December 2024 Accepted: 02 January 2025 Published: 09 January 2025